1. Homepage
  2. Equities
  3. United States
  4. OTC Markets
  5. Mentor Capital, Inc.
  6. News
  7. Summary
    MNTR   US5871831047

MENTOR CAPITAL, INC.

(MNTR)
Delayed OTC Markets  -  05/23 12:50:11 pm EDT
0.0500 USD    0.00%
05/16Mentor Capital Posts 40% Annual Revenue Gain in 10-Q
BU
05/13MENTOR CAPITAL, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
05/13Mentor Capital, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
SummaryQuotesChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

MENTOR CAPITAL, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)

05/13/2022 | 02:38pm EDT

The following discussion will assist in the understanding of our financial position at March 31, 2022 and the results of operations for the three months ended March 31, 2022 and 2021. The information below should be read in conjunction with the information contained in the unaudited Condensed Consolidated Financial Statements and related notes to the financial statements included within this Quarterly Report on Form 10-Q for the three months ended March 31, 2022 and 2021 and our Annual Report on Form 10-K for the year ended December 31, 2021.




Corporate Background



The Company's common stock trades publicly under the trading symbol OTCQB: MNTR.

In 2009 the Company began focusing its investing activities in leading-edge cancer companies. In response to government limitations on reimbursement for highly technical and expensive cancer treatments and a resulting business decline in the cancer immunotherapy sector, the Company decided to exit that space. In the summer of 2013, the Company was asked to consider investing in a cancer-related project with a medical marijuana focus. On August 29, 2013, the Company decided to fully divest its cancer assets and focus its next round of investments in the medical marijuana and cannabis sector. In late 2019, the Company expanded its target industry focus which now includes energy, medical products, manufacturing, cryptocurrency, real estate, and international projects with the goal of ensuring increased market opportunities and investment diversification.


Acquisitions and investments



Waste Consolidators, Inc. (WCI)

WCI is a long standing investment of which the Company owns a 51% interest and is included in the condensed consolidated financial statements for the three months ended March 31, 2022 and 2021. In the last half of 2020, WCI began expanding its services in Texas from San Antonio and Austin to include Houston, and in November 2021, WCI began services in Dallas. This has led to an increase in selling, general and administrative salaries as WCI positions itself to operate in this new location.

Electrum Partners, LLC (Electrum)

Electrum is a Nevada based consulting, investment, and management company. The Company's equity interest in Electrum is reported in the condensed consolidated balance sheets as an investment at cost of $194,028 and $194,028 at March 31, 2022 and December 31, 2021, respectively. At March 31, 2022 and December 31, 2021, the Company had approximately 6.69% and 6.69% interest of Electrum's outstanding equity, respectively.



-31-





On October 30, 2018, the Company entered into a secured Recovery Purchase Agreement with Electrum to purchase a portion of Electrum's potential recovery in its legal action captioned Electrum Partners, LLC, Plaintiff, and Aurora Cannabis Inc., Defendant, pending in the Supreme Court of British Columbia ("Litigation"). As of March 31, 2022 and December 31, 2021, Mentor has provided $196,666 and $196,666, respectively, in capital for payment of Litigation costs. In exchange, after repayment to Mentor of all funds invested for payment of Litigation costs, Mentor will receive 19% of anything of value received by Electrum as a result of the Litigation ("Recovery").

On October 31, 2018, Mentor entered into a secured Capital Agreement with Electrum and invested an additional $100,000 in Electrum. Due to the coronavirus and the resulting delay in the trial date of the Litigation, on November 1, 2021 the parties amended the October 31, 2018 Capital Agreement for the purpose of extending the payment to the earlier of November 1, 2023, or the final resolution of the Litigation and increasing the monthly payment payable by Electrum to $834. Under the amended Capital Agreement, on the payment date, Electrum will pay Mentor the sum of (i) $100,000, (ii) ten percent (10%) of the Recovery, and (iii) 0.083334% of the Recovery for each full month from October 31, 2018, to the payment date for each full month that the monthly payment is not paid to Mentor in full. The payment date for the Capital Agreement is the earlier of November 1, 2023, or the final resolution of the Litigation.

On January 28, 2019, the Company entered into a second secured Capital Agreement with Electrum and invested an additional $100,000 in Electrum with payment terms similar to the October 31, 2018 Capital Agreement. On November 1, 2021, the parties also amended the January 28, 2019 Capital Agreement to extend the payment date to the earlier of November 1, 2023, or the final resolution of the Litigation and increasing the monthly payment payable by Electrum to $834. As part of the January 28, 2019 Capital Agreement, Mentor was granted an option to convert its 6,198 membership interests in Electrum into a cash payment of $194,027.78 plus an additional 19.4% of the Recovery. See Note 8 to the condensed consolidated financial statements.

The Company is entitled to receive to 19% of anything of value received by Electrum as a result of the Recovery, following reimbursement to the Company of Litigation costs, see Note 8 to the condensed consolidated financial statements. Trial in the Electrum Litigation is currently scheduled to commence on October 3, 2022.




Mentor IP, LLC (MCIP)



On April 18, 2016, the Company formed Mentor IP, LLC ("MCIP"), a South Dakota limited liability company and wholly owned subsidiary of Mentor. MCIP was formed to hold interests related to patent rights obtained on April 4, 2016, when Mentor Capital, Inc. entered into that certain "Larson - Mentor Capital, Inc. Patent and License Fee Facility with Agreement Provisions for an - 80% / 20% Domestic Economic Interest - 50% / 50% Foreign Economic Interest" with R. L. Larson and Larson Capital, LLC ("MCIP Agreement"). Pursuant to the MCIP Agreement, MCIP obtained rights to an international patent application for foreign THC and CBD cannabis vape pens under the provisions of the Patent Cooperation Treaty of 1970, as amended. R. L. Larson continues its efforts to obtain exclusive licensing rights in the United States for THC and CBD cannabis vape pens for various THC and CBD percentage ranges and concentrations. Activity is currently limited to the annual payment of patent maintenance fees in Canada. On January 21, 2020, the United States Patent and Trademark Office granted a Notice of Allowance for the United States patent application, and on May 5, 2020, the United States patent was issued. On June 29, 2020, the Canadian Intellectual Property Office granted a Notice of Allowance for the Canada patent, and on September 22, 2020, the Canadian patent was issued. Patent application national phase maintenance fees were expensed when paid, and therefore, no capitalized assets related to MCIP are reported on the condensed consolidated financial statements at March 31, 2022 and December 31, 2021.



NeuCourt, Inc.


NeuCourt, Inc. is a Delaware corporation that is developing a technology that is expected to be useful to the dispute resolution industry.

On November 22, 2017, the Company invested $25,000 in NeuCourt, Inc. ("NeuCourt") as a convertible note receivable. The note bears interest at 5% per annum, originally matured November 22, 2019, and was amended to extend the maturity date to November 22, 2021. No payments are required prior to maturity. However, at the time the November 22, 2017 note was initially extended, interest accrued through November 4, 2019, was remitted to Mentor. As consideration for the initial extension of the maturity date for the $25,000 note, a warrant to purchase up to 25,000 shares of NeuCourt common stock at $0.02 per share was issued to Mentor. On November 5, 2021, the parties amended the note to extend the November 22, 2021 maturity date to November 22, 2023. A warrant to purchase 27,630 shares of NeuCourt common stock at $0.02 per share was issued to Mentor in exchange for the second extension of the maturity date.

On October 31, 2018, the Company invested an additional $50,000 as a convertible note receivable in NeuCourt, which bears interest at 5%, originally matured October 31, 2020, and was amended to extend the maturity date to October 31, 2022. As consideration for the extension of the maturity date for the $50,000 note plus accrued interest of $5,132, a warrant to purchase up to 52,500 shares of NeuCourt common stock at $0.02 per share was issued to Mentor. Principal and unpaid interest on the Notes may be converted into a blend of shares of a to-be-created series of Preferred Stock and Common Stock of NeuCourt (i) on the closing of a future financing round of at least $750,000, (ii) on the election of NeuCourt on the maturity of the Note, or (iii) on the election of Mentor following NeuCourt's election to prepay the Note.

On December 21, 2018, the Company purchased 500,000 shares of NeuCourt Common Stock for $10,000. This represents approximately 6.13% of the issued and outstanding NeuCourt shares at March 31, 2022.



-32-






Mentor Partner I, LLC


On September 19, 2017, the Company formed Mentor Partner I, LLC ("Partner I"), a California limited liability company as a wholly owned subsidiary of Mentor. Partner I was subsequently reorganized under the laws of the State of Texas. In 2018 and 2019, Mentor contributed $1,010,326 of capital to Partner I to facilitate the purchase of manufacturing equipment to be leased from Partner I by G FarmaLabs Limited ("G Farma") under a Master Equipment Lease Agreement dated January 16, 2018, as amended. Amendments expanded the Lessee under the agreement to include G FarmaLabs Limited and G FarmaLabs DHS, LLC (collectively referred to as "G Farma Lease Entities"). The finance leases resulting from this investment have been fully impaired at March 31, 2022 and December 31, 2021. Management considers collection on the leases to be unlikely, see Note 17 to the condensed consolidated financial statements.



Mentor Partner II, LLC


On February 1, 2018, the Company formed Mentor Partner II, LLC ("Partner II"), a California limited liability company, as a wholly owned subsidiary of Mentor. Partner II was subsequently reorganized under the laws of the State of Texas. On February 8, 2018, Mentor contributed $400,000 to Partner II to facilitate the purchase of manufacturing equipment to be leased from Partner II by Pueblo West under a Master Equipment Lease Agreement dated February 11, 2018, as amended see Note 7 to the condensed consolidated financial statements. On March 12, 2019, Mentor agreed to use Partner II's earnings of $61,368 to facilitate the purchase of additional manufacturing equipment to Pueblo West under a Second Amendment to the lease, see Note 7 to the condensed consolidated financial statements. Payment on the leases are current.



Overview


The Company expanded its target industry focus, beginning in the third quarter of 2019, from its investment in WCI and investments in the medical marijuana and social use cannabis sector to include energy, medical products, manufacturing, cryptocurrency, real estate, and international projects with the goal of ensuring increased market opportunities and investment diversification. Our general business operations are intended to provide management consultation and headquarters functions, especially with regard to accounting and audits, for our larger investment targets and our majority-owned subsidiaries. We monitor our smaller and less than majority positions for value and investment security. Management also spends considerable effort reviewing possible acquisition candidates on an ongoing basis.

Mentor seeks to take significant positions in the companies it invests in to provide public market liquidity for founders, protection for investors, funding for the companies, and to incubate private companies that Mentor believes to have significant potential. When Mentor takes a significant position in its investees, it provides financial management when needed but leaves operating control in the hands of the company founders. Retaining control, receiving greater liquidity, and working with an experienced organization to efficiently develop disclosures and compliance are three potential key advantages to founders working with Mentor Capital, Inc.

Because adult social use and medical marijuana opportunities often overlap, Mentor Capital has participated in the ancillary side of the legal recreational marijuana market. However, Mentor's preferred focus was medical, and the Company sought to facilitate the application of cannabis to cancer wasting, Parkinson's disease, calming seizures, reducing ocular pressures from glaucoma, and blunting chronic pain.




Business Segments



We generally manage our operations through two operating segments, cannabis and medical marijuana segment and our long-standing investment in WCI. WCI works with business park owners, governmental centers, and apartment complexes in Arizona and Texas to reduce their facilities' operating costs. In late 2019, Mentor expanded its target industry focus which now includes energy, medical products, manufacturing, cryptocurrency, real estate, and international projects with the goal of ensuring increased market opportunities and investment diversification.

Liquidity and Capital Resources

The Company's future success is dependent upon its ability to make a return on its investments, to generate positive cash flow, and to obtain sufficient capital from non-portfolio-related sources. Management believes they have approximately twelve months of operating resources on hand and can raise additional funds as may be needed to support their business plan and develop an operating, cash flow positive company.



-33-






Results of Operations


Three Months Ended March 31, 2022, compared to Three Months Ended March 31, 2021



Revenues


Revenue for the three months ended March 31, 2022 was $1,848,898 compared to $1,320,624 for the three months ended March 31, 2021 ("the prior year period"), an increase of $528,274 or 40.0%. This increase is due primarily to a $530,127 increase in WCI service fees.



Gross profit


Gross profit for the three months ended March 31, 2022 was $699,883 compared to $436,392 for the prior year period. Cost of goods sold relate to WCI and Partner II. WCI experienced gross profit of $690,866 or 37.5% of revenue for the three months ended March 31, 2021, compared to $425,521 or 32.5% for the prior year period, an increase of $265,345 with an increase of 2.5% in gross profit as a percentage of revenue. Partner II had gross profit of $9,017 for the three months ended March 31, 2022 as compared to $10,871 in the prior year period. Partner I did not have revenue for the three months ended March 31, 2022 and 2021.

The increase in WCI gross profit percentage was due largely to revenue increasing at a higher rate (40.5%) than costs of goods sold (30.3%). Labor and related costs increased by $177,942, or 31.6% over the prior year period.

Selling, general and administrative expenses

Our selling, general and administrative expenses for the three months ended March 31, 2022 was $668,507 compared to $601,135 for the prior year period, an increase of $67,312. We experienced an increase of $50,000 in management fees, an increase of $15,995 in professional fees, and an increase of $19,777 in other selling, general and administrative fees, partially offset by a decrease in outside services of ($24,460) for the three months ended March 31, 2022 as compared to the prior year period.



Other income and expense


Other income and expense, net, totaled ($18,866) for the three months ended March 31, 2022 compared to $17,572 for the prior year period, a decrease of ($36,438). We experienced a decrease of ($5,599) in net gain or (loss) from investments in securities, a ($41,930) loss from the modification of our investment in receivable, a decrease of ($10,000) from a Paycheck Protection Program loan forgiven in the prior period, a ($2,136) decrease in interest income and a ($6,137) increase in interest expense, partially offset by a $26,811 increase in gain on ROU asset disposal and a $2,553 increase in other income (expense).



Net results


The net result for the three months ended March 31, 2022 was a net loss attributable to Mentor of ($92,659) or ($0.004) per Mentor common share compared to a net loss attributable to Mentor in the prior year period of ($146,923) or ($0.006) per Mentor common share. Management will continue to make an effort to lower operating expenses and increase revenue and gross margin. The Company will continue to look for acquisition opportunities to expand its portfolio in companies that are positive for operating revenue or have the potential to become positive for operating revenue.



-34-





Liquidity and Capital Resources

Since our reorganization, we have raised capital through warrant holder exercise of warrants to purchase shares of Common Stock. At March 31, 2022 we had cash and cash equivalents of $490,648 and working capital of $575,333.

Operating cash outflows in the three months ended March 31, 2022 was $101,548, including ($1,060) of net loss, $15,890 non-cash depreciation and amortization, $36,656 non-cash amortization on right of use assets, $41,930 non-cash loss on modification of investment in installment receivable, a $51,648 increase in operating liabilities, and gains on investments of $750, partially offset by ($26,168) non-cash gain on ROU asset disposal, ($13,470) non-cash amortization of discount on our investment in account receivable, less an increase in accrued interest income of ($878), and an increase in operating assets of ($3,750).

Cash outflows from investing activities in the three months ended March 31, 2022 were ($9,602) due to purchase of property and equipment of ($5,422), down payments on right of use assets of ($4,280), offset by $100 proceeds from investment in receivable.

Net outflows from financing activities during the three months ended March 31, 2022 were ($55,237) consisting of payment on related party payable of ($21,950), payments on long-term debt of ($5,294), and payments on finance lease liabilities of ($42,339), partially offset by proceeds from warrants exercised to purchase shares of common stock of $14,346.

We will be required to raise additional funds through financing, additional collaborative relationships or other arrangements until we are able to raise revenues to a point of positive cash flow.

In addition, on February 9, 2015, in accordance with Section 1145 of the United States Bankruptcy Code and the Company's court-approved Plan of Reorganization, the Company announced a minimum 30 day partial redemption of up to 1% of the already outstanding Series D warrants to provide for the court specified redemption mechanism for warrants not exercised timely by the original holder or their estates. Company designees that applied during the 30 days paid 10 cents per warrant to redeem the warrant and then exercised the Series D warrant to purchase a share at the court specified formula of not more than one-half of the closing bid price on the day preceding the 30 day exercise period. In the Company's October 7, 2016 press release, Mentor stated that the 1% redemptions which were formerly priced on a calendar month schedule would subsequently be initiated and be priced on a random date to be scheduled after the prior 1% redemption is completed to prevent potential third party manipulation of share prices at month-end. The periodic partial redemptions may continue to be recalculated and repeated until such unexercised warrants are exhausted, or the partial redemption is otherwise temporarily paused, suspended, or truncated by the Company.

For the three months ended March 31, 2022, there were no redemptions of Series D Warrants. There were no redemptions of Series D Warrants in 2021. We believe that if warrants are redeemed and exercised, partial warrant redemptions would provide monthly cash in excess of what is required for monthly operations for an extending period of time while we are exploring other major sources of funding for further acquisitions.

Disclosure About Off-Balance Sheet Arrangements

We do not have any transactions, agreements, or other contractual arrangements that constitute off-balance sheet arrangements.

© Edgar Online, source Glimpses

All news about MENTOR CAPITAL, INC.
05/16Mentor Capital Posts 40% Annual Revenue Gain in 10-Q
BU
05/13MENTOR CAPITAL, INC. Management's Discussion and Analysis of Financial Condition and R..
AQ
05/13Mentor Capital, Inc. Reports Earnings Results for the First Quarter Ended March 31, 202..
CI
03/28Mentor Capital Reports 2021 Revenues of 26 cents per Share
BU
03/24MENTOR CAPITAL, INC. Management's Discussion and Analysis of Financial Condition and R..
AQ
03/24Tranche Update on Mentor Capital, Inc.'s Equity Buyback Plan announced on August 8, 201..
CI
03/24Mentor Capital, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
2021Mentor Capital Revenues Up 21.2% for the 3rd Quarter 2021
BU
2021MENTOR CAPITAL, INC. Management's Discussion and Analysis of Financial Condition and R..
AQ
2021Mentor Capital, Inc. Reports Earnings Results for the Third Quarter and Nine Months End..
CI
More news
Financials (USD)
Sales
Net income
Net Debt
P/E ratio
Yield
Capitalization 1,15 M 1,15 M -
EV / Sales -1
EV / Sales 0
Nbr of Employees 73
Free-Float 91,1%
Chart MENTOR CAPITAL, INC.
Duration : Period :
Mentor Capital, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
Chester Billingsley President, Chief Executive Officer & Director
Sara Billingsley Director-Business Operations
Robert Bernhard Meyer Secretary & Lead Independent Director
David G. Carlile Independent Director
Lori J. Stansfield Treasurer & Director
Sector and Competitors